Further researches could be focused on treatment responses or the prognostic role of some more frequent mutations (Such as ATG5 or ATG7) in PD due find more effective treatment and move into personalized medicine and target therapy area for PD [56]. This evidence concerns the gene ATG5 and Parkinson disease.